UNIGE document Scientific Article
previous document  unige:44519  next document
add to browser collection

Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes

Published in Journal of Nuclear Medicine. 2014, vol. 55, no. 9, p. 1459-66
Abstract PET and hybrid (PET/CT and PET/MR) imaging currently play a pivotal role in clinical diagnosis, staging and restaging, treatment, and surveillance of several diseases. As such, limiting the radiation exposure of special patients, such as pregnant women, from PET procedures is an important challenge that needs to be appropriately addressed because of the high sensitivity of the developing embryo/fetus to ionizing radiation. Therefore, accurate radiation dose calculation for the embryo/fetus and pregnant patient from common positron-emitting radiotracers is highly desired.
Keywords Dihydroxyphenylalanine/analogs & derivatives/pharmacokineticsFemaleFetus/radiation effectsFluorodeoxyglucose F18/pharmacokineticsHumansMolecular ImagingPheochromocytoma/radionuclide imagingPositron-Emission Tomography/methodsPregnancyRadiation Dosage
PMID: 25024424
Full text
Article (Published version) (1.1 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group Imagerie Médicale (TEP et TEMP) (542)
Project FNS: SNF 31003A-149957
(ISO format)
XIE, Tianwu, ZAIDI, Habib. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes. In: Journal of Nuclear Medicine, 2014, vol. 55, n° 9, p. 1459-66. doi: 10.2967/jnumed.114.141309 https://archive-ouverte.unige.ch/unige:44519

352 hits

1 download


Deposited on : 2015-01-06

Export document
Format :
Citation style :